REFERENCES
- Des Jarlais, D., Hagan, H., Friedman, S., Friedmann, P., Goldberg, D., & Frischer, M. (1995). Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA, 274(15), 1226–1231.
- Des Jarlais, D. C., Marmor, M., Paone, D., Titus, S., Shi, Q., & Perlis, T. (1996). HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet, 348(9033), 987–991. doi: S0140673696025366 [pii]
- Des Jarlais, D. C., Perlis, T., Arasteh,K., Torian, L. V., Beatrice, S., & Milliken, J. (2005). HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health, 95(8), 1439–1444. doi: AJPH.2003.036517 [pii] 10.2105/AJPH.2003.036517 [doi]